These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12370456)

  • 1. Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals.
    Salmon DP; Thomas RG; Pay MM; Booth A; Hofstetter CR; Thal LJ; Katzman R
    Neurology; 2002 Oct; 59(7):1022-8. PubMed ID: 12370456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating illiteracy from Alzheimer's disease by using neuropsychological assessments.
    Youn JH; Siksou M; Mackin RS; Choi JS; Chey J; Lee JY
    Int Psychogeriatr; 2011 Dec; 23(10):1560-8. PubMed ID: 21777502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative performance of mildly impaired patients with Alzheimer's disease and multiple cerebral infarctions on tests of memory and functional capacity.
    Zimmer NA; Hayden S; Deidan C; Loewenstein DA
    Int Psychogeriatr; 1994; 6(2):143-54. PubMed ID: 7865702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.
    Kraybill ML; Larson EB; Tsuang DW; Teri L; McCormick WC; Bowen JD; Kukull WA; Leverenz JB; Cherrier MM
    Neurology; 2005 Jun; 64(12):2069-73. PubMed ID: 15985574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced semantic fluency as an additional screening tool for subjects with questionable dementia.
    Lam LC; Ho P; Lui VW; Tam CW
    Dement Geriatr Cogn Disord; 2006; 22(2):159-64. PubMed ID: 16837791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
    Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
    Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.
    Fleisher AS; Sowell BB; Taylor C; Gamst AC; Petersen RC; Thal LJ;
    Neurology; 2007 May; 68(19):1588-95. PubMed ID: 17287448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological Profiles Differentiate Alzheimer Disease from Subcortical Ischemic Vascular Dementia in an Autopsy-Defined Cohort.
    Ramirez-Gomez L; Zheng L; Reed B; Kramer J; Mungas D; Zarow C; Vinters H; Ringman JM; Chui H
    Dement Geriatr Cogn Disord; 2017; 44(1-2):1-11. PubMed ID: 28595184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spanish version of the Mattis Dementia Rating Scale-2 for early detection of Alzheimer's disease and mild cognitive impairment.
    Boycheva E; Contador I; Fernández-Calvo B; Ramos-Campos F; Puertas-Martín V; Villarejo-Galende A; Bermejo-Pareja F
    Int J Geriatr Psychiatry; 2018 Jun; 33(6):832-840. PubMed ID: 28332732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological prediction of decline to dementia in nondemented elderly.
    Kluger A; Ferris SH; Golomb J; Mittelman MS; Reisberg B
    J Geriatr Psychiatry Neurol; 1999; 12(4):168-79. PubMed ID: 10616864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free and cued selective reminding test predicts progression to Alzheimer's disease in people with mild cognitive impairment.
    Grande G; Vanacore N; Vetrano DL; Cova I; Rizzuto D; Mayer F; Maggiore L; Ghiretti R; Cucumo V; Mariani C; Cappa SF; Pomati S
    Neurol Sci; 2018 Nov; 39(11):1867-1875. PubMed ID: 30051200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of clinical trial batteries in the measurement of Alzheimer's and Huntington's dementia.
    Mohr E; Walker D; Randolph C; Sampson M; Mendis T
    Int Psychogeriatr; 1996; 8(3):397-411. PubMed ID: 9116176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
    Park JH; Park H; Sohn SW; Kim S; Park KW
    Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease.
    Testa JA; Ivnik RJ; Boeve B; Petersen RC; Pankratz VS; Knopman D; Tangalos E; Smith GE
    J Int Neuropsychol Soc; 2004 Jul; 10(4):504-12. PubMed ID: 15327729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery].
    Barth S; Schönknecht P; Pantel J; Schröder J
    Fortschr Neurol Psychiatr; 2005 Oct; 73(10):568-76. PubMed ID: 16217697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
    Giovagnoli AR; Erbetta A; Reati F; Bugiani O
    Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological Testing in Pathologically Verified Alzheimer Disease and Frontotemporal Dementia: How Well Do the Uniform Data Set Measures Differentiate Between Diseases?
    Ritter AR; Leger GC; Miller JB; Banks SJ
    Alzheimer Dis Assoc Disord; 2017; 31(3):187-191. PubMed ID: 28005562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia.
    Canning SJ; Leach L; Stuss D; Ngo L; Black SE
    Neurology; 2004 Feb; 62(4):556-62. PubMed ID: 14981170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.